Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
about
Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes TargetingSynthetic Nanoparticles for Vaccines and ImmunotherapyInfluenza virosomes supplemented with GPI-0100 adjuvant: a potent vaccine formulation for antigen dose sparing.Disulfide-crosslinked polyion micelles for delivery of protein therapeutics.Current advances in research and clinical applications of PLGA-based nanotechnology.A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against ExpeEnhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.Application of nanotechnologies for improved immune response against infectious diseases in the developing worldIntracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy.Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.Clustered carbohydrates in synthetic vaccines.The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid)Biomaterials as vaccine adjuvants.Non-invasive administration of biodegradable nano-carrier vaccines.Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant.Nanotechnology-Based Cancer Vaccine.Nanoparticle Vaccines Against Infectious DiseasesPotential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems
P2860
Q28072997-B2384C18-C0CA-467A-82CA-5BF2A745F7D3Q28085375-BEA57D8C-E6EC-49EB-B3AF-11AACFC96CB8Q30353863-2C6E69C2-F1C6-4311-BAAB-ABFAC1EAEE7EQ30377933-66323C23-647F-4727-9B5C-F174ED375692Q30482916-5049EC71-6461-4E60-96B4-0CA63E11B45FQ33790313-BFAB746C-6FFA-4DF5-B467-B02BDF830721Q33820591-8A9D3112-7D46-4EC4-ABF2-6FB0D2E9AA19Q33894321-348B25FD-C132-4FD8-9870-53C29A79502DQ34785774-772F509D-8C57-46DC-B389-18264FAA7902Q34802680-C39667B8-3A09-4B50-9983-A3FC589EADD2Q34990420-D4373455-4391-4F47-9BA2-192B0FB677A0Q36257481-2041A4E7-AF58-4E62-BF46-E525B070669BQ36726849-ADAE959D-73E1-4668-9BAC-0569903CE7A3Q36844110-96A2CE23-2800-49E9-B9D1-36118D67D074Q37078472-D67E14A1-3451-46A3-B621-69333281D322Q37385919-ACD63787-9F69-495F-A38B-809F23F30BB3Q37596856-4ACB2365-D536-45FA-B8DC-AC989525E810Q38054112-D98B4D3E-A445-4633-B85A-3490B70633C0Q38285751-68FDFB87-EA20-4D82-BB6B-0686F5975268Q38676164-31C2051D-5398-49DC-8030-190482C35A67Q38692217-AE9AA8AE-3DB6-4C76-93A3-3268D2A446E1Q38912004-BB426DC6-0F7D-49A4-B383-5E9E0D9FC38AQ40482585-FFE134DF-CCA6-4F72-BB61-899D1AA9B64DQ42627924-9581D1DD-0D65-495E-8B40-310331E3020AQ44707238-AFD7BD4B-AE9C-498C-9391-1B9A07CF25BBQ52915318-B65CE88B-74BD-4C54-BC66-EF3A81906658Q58583890-56B07987-26FD-453A-913E-25FF105256ECQ59282464-74569E73-4BFB-4C38-BA95-C19257BD6E21
P2860
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@en
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@nl
type
label
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@en
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@nl
prefLabel
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@en
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@nl
P2093
P356
P1476
Enhanced antigen-specific prim ...... -glycolic acid) nanoparticles.
@en
P2093
John Samuel
Ommoleila Molavi
Praveen Elamanchili
Samar Hamdy
P2860
P304
P356
10.1002/JBM.A.31019
P577
2007-06-01T00:00:00Z